Westlife Foodworld: Independent Director Amisha Jain Resigns

Ms. Amisha Jain has resigned as a Non-Executive Independent Director of Westlife Foodworld Limited, with her resignation effective August 13, 2026. She cited significant work responsibilities in her current full-time role as MD & CEO as the reason for stepping down, aiming to dedicate more attention to her primary career. The company has accepted her resignation, and the details have been duly filed as per regulatory requirements.

Resignation of Independent Director

Westlife Foodworld Limited has announced the resignation of Ms. Amisha Jain from her position as a Non-Executive Independent Director. The resignation is effective from August 13, 2026. Ms. Jain has been a part of the Company’s Board since 2019, currently serving her second 5-year term.

Reason for Resignation

In her resignation letter, dated August 13, 2026, Ms. Jain stated that her decision stems from the heavy work responsibilities in her current role as MD & CEO. She believes she can no longer devote the necessary time and attention to her duties as an Independent Director of Westlife Foodworld Limited. She expressed a desire to focus on the requirements of her full-time career and confirmed that there were no other material reasons for her resignation.

Company Acknowledgment

The Company has acknowledged her resignation and confirmed that it has been accepted. Ms. Jain conveyed her gratitude for the association and wished the Board and the organization continued success.

Disclosure Details

As per the disclosure requirements under Regulation 30 read with Schedule III Part-A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of Ms. Jain’s resignation have been provided. The announcement includes her DIN (05114264). Ms. Jain also holds directorships in other listed entities, including Arvind Fashions Limited as an Executive Director and Godrej Consumer Products Limited as an Independent Director.

Source: BSE

Previous Article

ICICI Prudential Mutual Fund: Crosses 5% Stake in Dr. Reddy's Laboratories

Next Article

ICICI Prudential MF: Sells 2.06% Stake in Thyrocare Technologies